-
Izumi KM, Kaye KM, Kieff ED. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci USA 1997. 94:1447-1452.
-
Izumi KM, Kieff ED. The Epstein-Barr virus oncogene LMP1 engages TRADD to mediate B lymphocyte growth transformation and activate NF-κB. Proc Natl Acad Sci USA 1997. 94:12594-12597.
-
Izumi KM, Cahir-McFarland E, Chen Y, Riley EA, Rizzo D, Kieff E. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth
transformation. J. Virol. 1999. 73:9908-9916.
-
Kaye KM, Izumi, KM, Li, H, Johanssen E, Davidson D, Longnecker R, Kieff E. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. J. Virol. 1999. 73:10525-10530.
-
Izumi KM, McFarland EC, Ting AT, Riley EA, Seed B, Kieff E. The Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1) engages TNF receptor associated proteins TRADD and RIP but does not induce apoptosis or require RIP for NF-κB activation. Mol. Cell Biol. 1999. 19:5759-67.
-
Higuchi, M., Kieff, E. Izumi, K.M. The Epstein-Barr virus latent membrane protein 1 (LMP1) putative Janus Kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines. J. Virol. 2002. 76:455-9.
-
Higuchi, M., Izumi K.M., Kieff, E. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA 2001. 98:4675-80.
|
